WO2017170970A1 - Composition for controlling microsporidia in fishes and method for controlling microsporidia in fishes using same - Google Patents
Composition for controlling microsporidia in fishes and method for controlling microsporidia in fishes using same Download PDFInfo
- Publication number
- WO2017170970A1 WO2017170970A1 PCT/JP2017/013489 JP2017013489W WO2017170970A1 WO 2017170970 A1 WO2017170970 A1 WO 2017170970A1 JP 2017013489 W JP2017013489 W JP 2017013489W WO 2017170970 A1 WO2017170970 A1 WO 2017170970A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- substituted
- seafood
- fish
- controlling
- Prior art date
Links
- 0 *c1nc2cc(Sc3ccccc3)ccc2[n]1 Chemical compound *c1nc2cc(Sc3ccccc3)ccc2[n]1 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/50—1,3-Diazoles; Hydrogenated 1,3-diazoles
- A01N43/52—1,3-Diazoles; Hydrogenated 1,3-diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
- A01N47/08—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
- A01N47/10—Carbamic acid derivatives, i.e. containing the group —O—CO—N<; Thio analogues thereof
- A01N47/18—Carbamic acid derivatives, i.e. containing the group —O—CO—N<; Thio analogues thereof containing a —O—CO—N< group, or a thio analogue thereof, directly attached to a heterocyclic or cycloaliphatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Definitions
- the present invention relates to a composition for controlling microspores of seafood and a method for controlling microspores of seafood using the same.
- Microsporidia are a group of unicellular eukaryotes that parasitize the cells of various animals such as insects, crustaceans, seafood, and mammals, and many of them are pathogenic to these animals.
- microsporeworms that are pathogenic to seafood, (1) Amberjack, Hamachi encephalomyelitis-causing microsporidia, (2) Heterosporis anguillarum, which causes downy mildew in cultured eels (3) Glugea plecoglossi, etc.
- Buko becosis is an infectious disease of mojaco (brass fry) caused by the microsporidia Microsporidium seriolae, which is currently confirmed in Japan and Taiwan.
- Mojaco is infected with Microsporidium seriolae
- a cheese mass cyst (spore sac) that can be seen with the naked eye is formed in the muscle.
- the fish body becomes uneven as the surrounding muscle tissue melts.
- Beco's disease generally disappears with age, but part of it remains in the muscle at the time of shipment, which can greatly reduce the commercial value. For this reason, farmers have suffered significant economic losses.
- even in cultured amberjack although the types of microsporidia that cause it are different, the occurrence of downy mildew has become a problem and the damage is on the rise.
- Benzimidazole drugs are examples of drugs that have a high therapeutic effect on microsporidia in terrestrial animals including humans. For example, in an antibacterial activity test in a culture test, it has been reported that high antibacterial activity is observed for benzimidazole drugs or fumagillin against some microsporidia. In particular, albendazole (see the following formula) has been reported to exhibit high antibacterial activity against many microsporeworms (see Non-Patent Documents 3 to 7).
- benzimidazole-containing drugs including albendazole have become the first choice for encephalistosis in rabbits caused by human microsporidia and microsporidia as the causative agent (see Non-Patent Document 8). ).
- fumagillin which is an antibiotic against amoeba
- Ayu gulgeosis causal pathogen is a kind of microsporidia belonging to the subfamily of Apansporoblast.
- Glugea plecoglossi see Non-Patent Document 1
- eel beko disease a high therapeutic effect was observed. Has been reported.
- Benzimidazole drugs are approved in many countries as animal husbandry and human medicines for parasitic diseases. In Japan as well, as human body drugs, echinococcus control agent, escazole (main component: albendazole), as livestock medicine, facinex (main component: triclabendazole), roundworm, roundworm, whipworm Marine bantel (main component: fenbendazole (see the formula below) for trough puffer's aphids (heterobotulosis) as an insecticide, flumoxal (main component: fulbendazole), Maypol (main component: fenbendazole), and a marine product )) Is commercially available.
- fumagillin is not approved as a human body medicine or animal husbandry because of its low safety against animals.
- benzimidazole derivatives only changes in the protozoa morphology under a microscope after drug sensitization to the spiderfish gulgea disease have been confirmed.
- glugea anomala is a microsporidia with a pathological condition that is distinctly different from the genus Microsporidium, which is susceptible to the action of drugs in the bath because it makes cysts mainly on the body surface of fish, and forms cysts in the muscles. For this reason, it is not an exaggeration to say that there is no information on the control effect against the genus Microspodium, which is the most important from the viewpoint of productivity for aquaculture business.
- the present invention has been made in view of the above circumstances, and prevents the infection of sea urchin muscles or organs by microsporidia and / or suppresses the growth of microspores in seafood muscles or organs. And / or a composition for controlling microspores of seafood that is highly effective in controlling microsporeworms from the body of seafood and is excellent in safety, and control of microsporeworms of seafood using the same
- the purpose is to provide a method that can be effectively used in industry.
- a first aspect of the present invention that meets the above-described object is represented by the following general formula (I), prevents infection of microspores to muscles or organs of seafood and / or muscles or organs of seafood
- An object of the present invention is to provide a composition for controlling microspores of fish and shellfish containing one or more selected from the group consisting of compounds that produce a compound represented by formula (I) as an active ingredient. It is.
- R 2 represents an amino group, a functional group represented by the formula —NH—COOR 8 , a functional group represented by the formula —N ⁇ CHR 9 , a functional group represented by the formula —N ⁇ CR 10 (R 11 ),
- a functional group selected from the group consisting of a 2-thiazolyl group and an alkylthio group, R 4 , R 6 and R 7 are each independently a hydrogen atom, halogen atom, nitro group, sulfonic acid group, carboxyl group, cyano group, acyl group, alkyl group, cycloalkyl group, alkoxyl group, aryl group, From heteroaryl group, aryloxy group, heteroaryloxy group, substituted acyl group, substituted alkyl group, substituted cycloalkyl group, substituted alkoxyl group, substituted aryl group, substituted heteroaryl group, substituted aryloxy group, substituted heteroaryloxy group An atom or functional group selected
- the second aspect of the present invention is represented by the above general formula (I), prevents infection of microsporeworms to the muscles or organs of seafood and / or microscopically in the muscles or organs of seafood.
- a compound having an activity of inhibiting the growth of spores and / or eliminating microsporeworms from the body of fish and shellfish, a pharmaceutically acceptable salt thereof, and metabolism in the body of fish and shellfish, the above general formula (I) By providing a method for controlling microsporeworms in fish and shellfish, comprising the step of administering to the fish and shellfish a composition comprising one or more selected from the group consisting of compounds that produce the compound represented by It solves the problem.
- the composition is represented by the general formula (I).
- the compound that produces the compound represented by the general formula (I) is represented by the following formula (8): )
- the seafood is, for example, perch It may be a fish belonging to (Perciformes) or the flounder (Pleuronectiformes).
- the fish and shellfish are periwinkle.
- Tuna genus Thunnus
- Persimmonidae Carangidae
- Buri Buri
- Persimmonidae Sparidae
- Red sea bream Chorysophrys
- Lepidoptera Paralichthyidae
- Flatfish Paralichthys
- flounder It may be a fish belonging to the genus Pleuronectidae (Verasper).
- the microsporeworm is, for example, Microsporidium. It may be a microsporeworm belonging to the genus.
- the microsporeworm is Microsporidium seriolae. There may be.
- the composition may be, for example, an oral administration agent, a feed for fish farming, an injection, or a bath powder. Good.
- control of microsporeworms means prevention of infection of microsporeworms, prevention of growth of microsporeworms that have entered (infected) the body of seafood, extermination and other muscles of A seafood Or it refers to the prevention of microspore invasion into organs and the management of the population (including extermination and killing).
- the administration to the seafood may be oral administration.
- the first of the present invention is an oral preparation.
- the composition for controlling microspores of fish and shellfish according to the embodiment is applied once or a plurality of times at intervals of 1 day or more and 180 days or less so that the dose of the active ingredient is 0.1 mg / kg or more and 100 mg / kg or less.
- the composition for controlling microsporeworms of fish and shellfish according to the first aspect of the present invention, which is an oral preparation may be effective for preventing the infection of fish and shellfish by oral administration.
- the microsporeworms of fish and shellfish may be controlled by oral administration once or multiple times at intervals of 6 hours or more and 180 days or less so that the dose of the component is 20 mg / kg or more and 400 mg / kg or less. .
- the composition for controlling microsporeworms of seafood according to the first aspect of the present invention which is an oral agent, is used as an active ingredient thereof. Even if the dose is 20 mg / kg or more and 400 mg / kg or less, it is administered orally several times at intervals of 3 days or more and 180 days or less to control the microsporidia of seafood and prevent reinfection. Good.
- oral administration may be performed at intervals of 5 days or more and 21 days or less, and the plurality of oral administrations may be defined as one cycle, and the cycle may be repeated at intervals of 3 days or more and 180 days or less.
- the administration to the seafood may be intramuscular injection or intraperitoneal injection.
- the administration to the fish and shellfish may be immersion in a medicine bath, and in this case, it is a medicine bath.
- Immersion in fish and shellfish in a medicinal bath solution containing the composition for controlling microspores of fish and shellfish according to the first aspect of the present invention in an amount such that the concentration of the active ingredient is 1 to 1000 ppm. Administration may be performed.
- the present invention it is possible to prevent infection of microsporeworms in muscles or organs of seafood and / or suppress the growth of microsporeworms in muscles or organs of seafood, and / or the body of seafood.
- the present invention provides a composition for controlling microspores of seafood that is highly effective in controlling microsporeworms and is excellent in safety, and a method for controlling microspores of seafood using the same.
- composition for controlling microspores of seafood according to the first embodiment of the present invention (hereinafter sometimes referred to as “composition for controlling microspores of seafood” or simply “composition”) .) Is represented by the following general formula (I), and prevents the infection of fish and muscles or organs with microsporeworms and / or the growth of microspores in fish and shellfish muscles or organs: It is represented by the following general formula (I) by a compound having an activity of inhibiting and / or eliminating microsporeworms from the body of fish and shellfish, a pharmaceutically acceptable salt thereof, and metabolism in the body of fish and shellfish One or more selected from the group consisting of compounds that produce compounds (prodrugs) are included as active ingredients.
- R 2 represents an amino group, a functional group represented by the formula —NH—COOR 8 , a functional group represented by the formula —N ⁇ CHR 9 , a functional group represented by the formula —N ⁇ CR 10 (R 11 ),
- a functional group selected from the group consisting of a 2-thiazolyl group and an alkylthio group, R 4 , R 6 and R 7 are each independently a hydrogen atom, halogen atom, nitro group, sulfonic acid group, carboxyl group, cyano group, acyl group, alkyl group, cycloalkyl group, alkoxyl group, aryl group, From heteroaryl group, aryloxy group, heteroaryloxy group, substituted acyl group, substituted alkyl group, substituted cycloalkyl group, substituted alkoxyl group, substituted aryl group, substituted heteroaryl group, substituted aryloxy group, substituted heteroaryloxy group An atom or functional group selected
- the substituted or unsubstituted alkyl group in the general formula (I) is preferably an alkyl group having 1 to 6 carbon atoms, preferably 1 to 3 carbon atoms. Included in the above general formula (I) are a substituted or unsubstituted alkylthio group, a substituted or unsubstituted acyl group, a substituted or unsubstituted alkoxyl group, and a substituted or unsubstituted alkyl sulfoxide group (alkylsulfinyl group).
- the alkyl groups are each independently an alkyl group having 1 to 6 carbon atoms, preferably 1 to 3 carbon atoms.
- the substituted or unsubstituted cycloalkyl group is preferably a cycloalkyl having 3 to 7 carbon atoms.
- the substituted or unsubstituted aryl group in the above general formula is preferably a phenyl group.
- a phenyl group is preferred.
- a halogen atom can be mentioned as a substituent of an aryl group.
- Examples of the substituted phenyl group include a 4-fluorophenyl group and a 2,3-dichlorophenyl group.
- Examples of the acyl group having a substituted or unsubstituted aryl group include a phenylcarbonyl group and a 4-fluorophenylcarbonyl group.
- An example of a substituted aryloxy group is a 2,3-dichlorophenyloxy group.
- Examples of the alkylthio group include a methylsulfanyl group, an ethylsulfanyl group, and a propylsulfanyl group.
- Examples of the arylthio group include a phenylthio group.
- alkyl sulfoxide group examples include a methylsulfinyl group, an ethylsulfinyl group, and a propylsulfinyl group.
- aryl sulfoxide group examples include a phenylsulfinyl group.
- Benzimidazole is a compound composed of a complex ring of benzene and imidazole (benzimidazole ring) as shown in the general formula (I), and this skeleton is strong against tubulin in nematode and microsporidia cells. By binding, it is thought to exert an anthelmintic action by inhibiting the polymerization action of intracellular microtubules. Moreover, the difference in antibacterial activity is recognized by the difference in the functional group of a side chain (reference literature: E.Lacey. Mode of action of benzimidazoles. Parasitology Today 1990, 6, p112-115.).
- the active ingredient of the control composition is a benzimidazole derivative, and the benzimidazole derivative containing a basic functional group such as an amino group or an acidic functional group such as a carboxylic acid group or a sulfonic acid group as a substituent.
- Pharmaceutically acceptable salts and compounds that produce benzimidazole derivatives or pharmaceutically acceptable salts thereof by metabolism in the body of fish and shellfish (not necessarily containing a benzimidazole ring).
- the active ingredient may be one of these, or a mixture containing any two or more of them in any proportion.
- compositions include alkali metal salts such as sodium salt and potassium salt, alkaline earth metal salts such as magnesium salt and calcium salt, ammonium salt, acetate salt, propionate salt, butyrate salt, Organic acid salts such as lactate, tartrate, citrate, succinate, fumarate and maleate, inorganic acid salts such as hydrochloride, nitrate, sulfate, hydrogensulfate, carbonate, bicarbonate Is mentioned.
- alkali metal salts such as sodium salt and potassium salt
- alkaline earth metal salts such as magnesium salt and calcium salt
- ammonium salt such as acetate salt, propionate salt, butyrate salt
- Organic acid salts such as lactate, tartrate, citrate, succinate, fumarate and maleate
- inorganic acid salts such as hydrochloride, nitrate, sulfate, hydrogensulfate, carbonate, bicarbonate Is mentioned.
- the prodrug of the compound represented by the general formula (I), a pharmaceutically acceptable salt thereof, and a compound that generates the compound represented by the general formula (I) include the following formula (1) ) To (10).
- the compound of the formula (8) is an albendazole prodrug
- the compound of the formula (9) is a fenbendazole prodrug.
- fenbendazole represented by formula (1) albendazole represented by formula (3)
- flubendazole represented by formula (6) and formula (10) are particularly preferable.
- the target seafood is not particularly limited.
- fish belonging to the order Perciformes or Pleuronectiformes and particularly belonging to the genus Scombridae, Thunnus, bluefin tuna, southern bluefin tuna , Bigeye, yellowfin, etc.
- target microsporidia is not particularly limited, for example, it belongs to the genus Microsporidium, and in particular, Microsporidium seriolae, which is a causative agent of yellowtail rot.
- composition for controlling microspores of seafood may take any form suitable for administration to seafood, and specific examples include oral preparations, injections, and bath preparations. .
- These compositions may contain components other than at least one active ingredient selected from any pharmaceutically acceptable carrier, solvent, excipient, spreading agent and other additives.
- Known or conventionally used carriers, solvents, excipients, spreading agents and other additives can be used.
- it comprises a compound represented by general formula (I) and a pharmaceutically acceptable salt thereof, and a compound that generates a compound represented by general formula (I) by metabolism in the body of fish and shellfish. At least one selected from the group can be used as an active ingredient of the composition for controlling microsporeworms.
- a compound represented by the general formula (I) and a pharmaceutically acceptable salt thereof and a compound that produces a compound represented by the general formula (I) by metabolism in the body of fish and shellfish.
- At least one selected can be used as an active ingredient in the production of a composition for controlling microsporeworms.
- the composition for controlling microsporidia at least one active ingredient selected from any of the above-mentioned pharmaceutically acceptable carriers, solvents, excipients, spreading agents and other additives. These ingredients may be blended. Therefore, this invention includes the usage method in manufacture of the composition for microspore insect control of such an active ingredient.
- control method of microspores of fish and shellfish The method for controlling microspores of fish and shellfish according to the second embodiment of the present invention (hereinafter sometimes referred to as “control method of microspores of fish and shellfish” or simply “control method”).
- control method of microspores of fish and shellfish Represented by the above general formula (I), preventing the infection of seafood muscles or organs with microsporeworms and / or suppressing the growth of microspores in seafood muscles or organs, and / or Or from a compound that has the activity of controlling microsporidia from the body of fish and shellfish, a pharmaceutically acceptable salt thereof, and a compound that generates the compound represented by the general formula (I) by metabolism in the body of fish and shellfish
- description is abbreviate
- any administration method is particularly applicable as long as it can be applied to the seafood.
- the administration method include oral administration, injection (intramuscular injection, intraperitoneal injection), and immersion administration in a drug bath.
- administration in any form suitable for oral administration is possible, but it is convenient and preferable to ingest with feed in the form of inclusion in feed during feeding.
- the dose, administration interval, and administration period are appropriately adjusted according to the target seafood, the type of microsporeworm to be controlled, and the purpose of administration (for example, prevention (infection prevention), extermination, etc.).
- prevention prevention
- extermination etc.
- the composition is administered orally multiple times. By administering the composition for controlling microspores of fish and shellfish at such doses and intervals, the effect of preventing microspore infections is maintained for at least about 4 weeks after the end of the administration.
- control of microsporidia it is orally administered once or multiple times at intervals of 6 hours or more and 180 days or less so that the dose of the active ingredient is 20 mg / kg or more and 400 mg / kg or less.
- the dose for each administration may be changed, and the administration interval may not be constant.
- the dose of the active ingredient is 20 mg / kg or more and 400 mg / kg or less, preferably 3 days or more and 180 days or less, more preferably 5 days or more and 21 days or less
- the composition for controlling microspores of seafood may be orally administered multiple times.
- the composition for controlling microspores of fish and shellfish is administered at such doses and intervals, the composition for controlling microspores of fish and shellfish per time increases, but between each time of administration
- fish and shellfish will acquire immunity to microsporidia and the reinfection prevention effect of microsporidia will last for a long period of time, and the total dose of the composition for controlling microspores of seafood Can be reduced.
- the plurality of oral administrations described above may be one cycle, and this administration cycle may be repeated at intervals of 3 days or more and 180 days or less.
- the concentration of the active ingredient in the chemical bath solution is, for example, 0.1 to 1000 ppm.
- the most preferable concentration and time are 10 mg / kg and 2 hours, but since the effect and toxicity differ depending on the water temperature, it is necessary to adjust while observing the state of the fish.
- Administration may be single or multiple.
- the concentration of the active ingredient in the chemical bath, the soaking time for each time, and the administration interval are appropriately adjusted according to the drug metabolism status of the target fish.
- the administration interval may be constant as in the case of oral administration, or may be changed every time.
- the concentration of the active ingredient in the injection solution is, for example, 1 mg to 300 mg / kg.
- Administration may be single or multiple.
- the most preferred concentration is 10 to 100 mg / kg, and the concentration of active ingredient and the administration interval may be constant as in the case of oral administration, or may be changed each time.
- test group control group (test was conducted under the same conditions as described above except that the feed fed did not contain fenbendazole), fenbendazole group)
- 10 mojakos were taken out from each of them and dropped into 3 pieces, and it was visually inspected for microsporeworm cysts (becocysts) in one body. If becocyst was observed, it was determined as positive and counted. The number of becocysts confirmed with the naked eye was confirmed, and the average number of infections per fish was determined.
- Table 1 shows the inspection results.
- the number of positives in the control group was 8 out of 10
- the number of positives in the fenbendazole group was 6 out of 10 animals, and no significant difference was observed.
- the average number of becocysts per fish is 8.0 ⁇ 5.20 for the control group, while it is 3.5 ⁇ 3.83 for the fenbendazole group. Significant differences were observed within 5%.
- Table 2 shows the inspection results.
- the prevention test was conducted according to the following procedure. ⁇ Test cage 5m ⁇ 5m ⁇ 5m ⁇ Number of test fish 1000 (starting weight 7g) ⁇ Administration method Oral administration (feeding with spreading agent) Test period 2 months Drug Albendazole (compound represented by the above formula (3)) ⁇ Dose 20mg / kg Bw (20mg per kg fish weight) ⁇ Dose interval 6 times / week
- Sampling inspection was performed according to the following procedure. Every 2 weeks from the start of administration, 20 mojaco (100 fish in the 8th week after the start of administration) are picked up from each test group, dropped into 3 pieces, and microsporeworm cysts (becocysts) are observed on one side Inspect visually. If becocyst is found, it is determined as positive and counted. The number of becocysts confirmed with the naked eye is confirmed, and the average number of infections per animal is determined.
- Table 4 shows the changes in the weight of Mojaco subjected to the test.
- the dose and administration interval of albendazole per time are as described in 1-1.
- the prevention of becopathic infection did not continue until 8 weeks after the end of the administration of albendazole, and the occurrence of becocysts was confirmed.
- the end of the administration of albendazole It was confirmed that the occurrence of becocysts was greatly suppressed even after the lapse of 8 weeks (24 weeks after the start of administration).
- the becocysts confirmed in Test Zone 2 are old and hardened and are not considered to have newly occurred after the administration of albendazole. From these results, it was suggested that the resistance to reinfection of Beco's disease was acquired in Test Group 2 by administering albendazole by a different administration method from Test Group 1.
- the microsporeworm ⁇ -tubulin gene which is a pathogen of seafood shows a high homology with the microsporeworm ⁇ -tubulin gene sensitive to benzimidazole drugs, Furthermore, it can be presumed that a benzimidazole drug is highly likely to be a microsporeworm control drug for those whose codon 198 is glutamic acid. Therefore, the ⁇ -tubulin gene was isolated from microsporidia that were infectious to various fish and shellfish, amplified by PCR, sequencing and amino acid sequence confirmation. The results are shown in Table 10 below.
- the amino acid sequence of ⁇ -tubulin from rabbit-derived microsporidia that is sensitive to benzimidazole drugs is highly homologous to the amino acid sequence of ⁇ -tubulin from yellowtail, amberjack, bluefin tuna, red sea bream, and flounder It was. Furthermore, the microsporeworm ⁇ -tubulin gene codon 198 derived from these fish was all glutamic acid (E). From the above test results, it was suggested that the microspores derived from red sea bream, hoshigarei and bluefin tuna may be sensitive to benzimidazole.
- Example 2 Treatment test 2-1. Therapeutic test of downy mildew-infected mojaco using albendazole The therapeutic test was performed according to the following procedure. ⁇ Test cage 5m ⁇ 5m ⁇ 5m ⁇ Number of test fish: 100 (tests were conducted by selecting fish that were clearly infected with downy mildew by visual inspection at the time of vaccination) ⁇ Administration method Oral administration (feeding with spreading agent) Test period 2 months Drug Albendazole (compound represented by the above formula (3)) ⁇ Dose 50mg / kg Bw (50mg / kg fish weight) ⁇ Dose interval 6 times / week
Abstract
Description
(1)カンパチ、ハマチの脳脊髄炎原因微胞子虫、
(2)養殖ウナギにベコ病を生じるHeterosporis anguillarum、
(3)アユのグルゲア症の原因となるGlugea plecoglossi等、
(4)ニジマスの武田微胞子虫症の原因となるMicrosporidium takedai、
(5)ブリのベコ病の原因となるMicrosporidium seriolae、
(6)養殖エビでの微胞子虫症であるEnterocytozoon hepatopenaei等
が知られている。 Microsporidia are a group of unicellular eukaryotes that parasitize the cells of various animals such as insects, crustaceans, seafood, and mammals, and many of them are pathogenic to these animals. As microsporeworms that are pathogenic to seafood,
(1) Amberjack, Hamachi encephalomyelitis-causing microsporidia,
(2) Heterosporis anguillarum, which causes downy mildew in cultured eels
(3) Glugea plecoglossi, etc. that cause Ayu gurugeosis
(4) Microsporidium takedai causing rainbow trout in Takeda microsporidia,
(5) Microsporidium seriolae that causes downy mildew
(6) Enterocytozoon hepatopenaei, which is microsporidia in cultured shrimp, is known.
R2は、アミノ基、式-NH-COOR8で表される官能基、式-N=CHR9で表される官能基、式-N=CR10(R11)で表される官能基、2-チアゾリル基、アルキルチオ基からなる群より選択される官能基であり、
R4、R6、R7は、それぞれ独立して、水素原子、ハロゲン原子、ニトロ基、スルホン酸基、カルボキシル基、シアノ基、アシル基、アルキル基、シクロアルキル基、アルコキシル基、アリール基、ヘテロアリール基、アリールオキシ基、ヘテロアリールオキシ基、置換アシル基、置換アルキル基、置換シクロアルキル基、置換アルコキシル基、置換アリール基、置換ヘテロアリール基、置換アリールオキシ基、置換ヘテロアリールオキシ基からなる群より選択される原子又は官能基であり、
R5は、水素原子、アミノ基、式-NH-COOR12で表される官能基、アルコキシル基、アルキルチオ基、アリールチオ基、アルキルスルホキシド基(アルキルスルフィニル基)、アリールスルホキシド基(アリールスルフィニル基)、アシル基、置換アルコキシル基、置換アルキルチオ基、置換アルキルスルホキシド基(置換アルキルスルフィニル基)、置換アリールスルホキシド基(置換アリールスルフィニル基)、置換アシル基、ハロゲン基、アリールオキシ基、置換アリールオキシ基及びR13-CO-NH-(R13はアルキル基)からなる群より選択される原子又は官能基であり、
R8、R9、R10、R11、R12は、それぞれ独立して、アルキル基、シクロアルキル基、アルコキシル基、アリール基、ヘテロアリール基、置換アシル基、置換アルキル基、置換シクロアルキル基、置換アルコキシル基、置換アリール基、置換ヘテロアリール基からなる群より選択される原子又は官能基である。 In the general formula (I),
R 2 represents an amino group, a functional group represented by the formula —NH—COOR 8 , a functional group represented by the formula —N═CHR 9 , a functional group represented by the formula —N═CR 10 (R 11 ), A functional group selected from the group consisting of a 2-thiazolyl group and an alkylthio group,
R 4 , R 6 and R 7 are each independently a hydrogen atom, halogen atom, nitro group, sulfonic acid group, carboxyl group, cyano group, acyl group, alkyl group, cycloalkyl group, alkoxyl group, aryl group, From heteroaryl group, aryloxy group, heteroaryloxy group, substituted acyl group, substituted alkyl group, substituted cycloalkyl group, substituted alkoxyl group, substituted aryl group, substituted heteroaryl group, substituted aryloxy group, substituted heteroaryloxy group An atom or functional group selected from the group consisting of
R 5 represents a hydrogen atom, an amino group, a functional group represented by the formula —NH—COOR 12 , an alkoxyl group, an alkylthio group, an arylthio group, an alkyl sulfoxide group (an alkylsulfinyl group), an aryl sulfoxide group (an arylsulfinyl group), Acyl group, substituted alkoxyl group, substituted alkylthio group, substituted alkyl sulfoxide group (substituted alkylsulfinyl group), substituted aryl sulfoxide group (substituted arylsulfinyl group), substituted acyl group, halogen group, aryloxy group, substituted aryloxy group and R An atom or a functional group selected from the group consisting of 13 —CO—NH— (R 13 is an alkyl group);
R 8 , R 9 , R 10 , R 11 , R 12 are each independently an alkyl group, cycloalkyl group, alkoxyl group, aryl group, heteroaryl group, substituted acyl group, substituted alkyl group, substituted cycloalkyl group , A substituted alkoxyl group, a substituted aryl group, or a substituted heteroaryl group.
本発明の第1の実施の形態に係る魚介類の微胞子虫の防除用組成物(以下、「魚介類の微胞子虫の防除用組成物」又は単に「組成物」と略称する場合がある。)は、下記の一般式(I)で表され、魚介類の筋肉又は臓器への微胞子虫の感染を予防し、かつ/又は魚介類の筋肉又は臓器中での微胞子虫の増殖を抑制し、かつ/又は魚介類の体内から微胞子虫を駆除する活性を有する化合物、その薬学的に許容される塩及び魚介類の体内での代謝により下記の一般式(I)で表される化合物を生成する化合物(プロドラッグ)からなる群より選択される1又は複数を有効成分として含んでいる。 [First Embodiment]
Composition for controlling microspores of seafood according to the first embodiment of the present invention (hereinafter sometimes referred to as “composition for controlling microspores of seafood” or simply “composition”) .) Is represented by the following general formula (I), and prevents the infection of fish and muscles or organs with microsporeworms and / or the growth of microspores in fish and shellfish muscles or organs: It is represented by the following general formula (I) by a compound having an activity of inhibiting and / or eliminating microsporeworms from the body of fish and shellfish, a pharmaceutically acceptable salt thereof, and metabolism in the body of fish and shellfish One or more selected from the group consisting of compounds that produce compounds (prodrugs) are included as active ingredients.
R2は、アミノ基、式-NH-COOR8で表される官能基、式-N=CHR9で表される官能基、式-N=CR10(R11)で表される官能基、2-チアゾリル基、アルキルチオ基からなる群より選択される官能基であり、
R4、R6、R7は、それぞれ独立して、水素原子、ハロゲン原子、ニトロ基、スルホン酸基、カルボキシル基、シアノ基、アシル基、アルキル基、シクロアルキル基、アルコキシル基、アリール基、ヘテロアリール基、アリールオキシ基、ヘテロアリールオキシ基、置換アシル基、置換アルキル基、置換シクロアルキル基、置換アルコキシル基、置換アリール基、置換ヘテロアリール基、置換アリールオキシ基、置換ヘテロアリールオキシ基からなる群より選択される原子又は官能基であり、
R5は、水素原子、アミノ基、式-NH-COOR12で表される官能基、アルコキシル基、アルキルチオ基、アリールチオ基、アルキルスルホキシド基(アルキルスルフィニル基)、アリールスルホキシド基(アリールスルフィニル基)、アシル基、置換アルコキシル基、置換アルキルチオ基、置換アルキルスルホキシド基(置換アルキルスルフィニル基)、置換アリールスルホキシド基(置換アリールスルフィニル基)、置換アシル基、ハロゲン基、アリールオキシ基、置換アリールオキシ基及びR13-CO-NH-(R13はアルキル基)からなる群より選択される原子又は官能基であり、
R8、R9、R10、R11、R12は、それぞれ独立して、アルキル基、シクロアルキル基、アルコキシル基、アリール基、ヘテロアリール基、置換アシル基、置換アルキル基、置換シクロアルキル基、置換アルコキシル基、置換アリール基、置換ヘテロアリール基からなる群より選択される原子又は官能基である。
上記一般式(I)における置換または未置換のアルキル基としては、炭素数1~6、好ましくは炭素数1~3のアルキル基が好ましい。
上記一般式(I)における、置換または未置換のアルキルチオ基、置換または未置換のアシル基、置換または未置換のアルコキシル基、並びに、置換または未置換のアルキルスルホキシド基(アルキルスルフィニル基)に含まれるアルキル基はそれぞれ独立して炭素数1~6、好ましくは炭素数1~3のアルキル基が好ましい。
置換または未置換のシクロアルキル基としては、炭素数3~7のシクロアルキルが好ましい。
上記一般式における置換または未置換のアリール基としては、フェニル基が好ましい。
上記一般式(I)における置換または未置換のアリールオキシ基、置換または未置換のアシル基、置換または未置換のアリールチオ基、置換または未置換のアリールスルホキシド基(アリールスルファニル基)のアリール基としては、フェニル基が好ましい。
アリール基の置換基としては、ハロゲン原子を挙げることができる。
置換フェニル基としては、4-フルオロフェニル基、2,3-ジクロロフェニル基を挙げることができる。
置換または未置換のアリール基を有するアシル基としては、フェニルカルボニル基、4-フルオロフェニルカルボニル基を挙げることができる。
置換アリールオキシ基としては、2,3-ジクロロフェニルオキシ基を挙げることができる。
アルキルチオ基としては、メチルスルファニル基、エチルスルファニル基及びプロピルスルファニル基を挙げることができる。
アリールチオ基としては、フェニルチオ基を挙げることができる。
アルキルスルホキシド基(アルキルスルフィニル基)としては、メチルスルスルフィニル基、エチルスルフィニル基、プロピルスルフィニル基を挙げることができる。
アリールスルホキシド基(アリールスルフィニル基)としては、フェニルスルフィニル基を挙げることができる。 In the general formula (I),
R 2 represents an amino group, a functional group represented by the formula —NH—COOR 8 , a functional group represented by the formula —N═CHR 9 , a functional group represented by the formula —N═CR 10 (R 11 ), A functional group selected from the group consisting of a 2-thiazolyl group and an alkylthio group,
R 4 , R 6 and R 7 are each independently a hydrogen atom, halogen atom, nitro group, sulfonic acid group, carboxyl group, cyano group, acyl group, alkyl group, cycloalkyl group, alkoxyl group, aryl group, From heteroaryl group, aryloxy group, heteroaryloxy group, substituted acyl group, substituted alkyl group, substituted cycloalkyl group, substituted alkoxyl group, substituted aryl group, substituted heteroaryl group, substituted aryloxy group, substituted heteroaryloxy group An atom or functional group selected from the group consisting of
R 5 represents a hydrogen atom, an amino group, a functional group represented by the formula —NH—COOR 12 , an alkoxyl group, an alkylthio group, an arylthio group, an alkyl sulfoxide group (an alkylsulfinyl group), an aryl sulfoxide group (an arylsulfinyl group), Acyl group, substituted alkoxyl group, substituted alkylthio group, substituted alkyl sulfoxide group (substituted alkylsulfinyl group), substituted aryl sulfoxide group (substituted arylsulfinyl group), substituted acyl group, halogen group, aryloxy group, substituted aryloxy group and R An atom or a functional group selected from the group consisting of 13 —CO—NH— (R 13 is an alkyl group);
R 8 , R 9 , R 10 , R 11 , R 12 are each independently an alkyl group, cycloalkyl group, alkoxyl group, aryl group, heteroaryl group, substituted acyl group, substituted alkyl group, substituted cycloalkyl group , A substituted alkoxyl group, a substituted aryl group, or a substituted heteroaryl group.
The substituted or unsubstituted alkyl group in the general formula (I) is preferably an alkyl group having 1 to 6 carbon atoms, preferably 1 to 3 carbon atoms.
Included in the above general formula (I) are a substituted or unsubstituted alkylthio group, a substituted or unsubstituted acyl group, a substituted or unsubstituted alkoxyl group, and a substituted or unsubstituted alkyl sulfoxide group (alkylsulfinyl group). The alkyl groups are each independently an alkyl group having 1 to 6 carbon atoms, preferably 1 to 3 carbon atoms.
The substituted or unsubstituted cycloalkyl group is preferably a cycloalkyl having 3 to 7 carbon atoms.
The substituted or unsubstituted aryl group in the above general formula is preferably a phenyl group.
As the aryl group of the substituted or unsubstituted aryloxy group, substituted or unsubstituted acyl group, substituted or unsubstituted arylthio group, substituted or unsubstituted aryl sulfoxide group (arylsulfanyl group) in the above general formula (I), A phenyl group is preferred.
A halogen atom can be mentioned as a substituent of an aryl group.
Examples of the substituted phenyl group include a 4-fluorophenyl group and a 2,3-dichlorophenyl group.
Examples of the acyl group having a substituted or unsubstituted aryl group include a phenylcarbonyl group and a 4-fluorophenylcarbonyl group.
An example of a substituted aryloxy group is a 2,3-dichlorophenyloxy group.
Examples of the alkylthio group include a methylsulfanyl group, an ethylsulfanyl group, and a propylsulfanyl group.
Examples of the arylthio group include a phenylthio group.
Examples of the alkyl sulfoxide group (alkylsulfinyl group) include a methylsulfinyl group, an ethylsulfinyl group, and a propylsulfinyl group.
Examples of the aryl sulfoxide group (arylsulfinyl group) include a phenylsulfinyl group.
なお、式(8)の化合物はアルベンダゾールのプロドラックであり、式(9)の化合物は、フェンベンダゾールのプロドラックである。 Preferable examples of the prodrug of the compound represented by the general formula (I), a pharmaceutically acceptable salt thereof, and a compound that generates the compound represented by the general formula (I) include the following formula (1) ) To (10).
The compound of the formula (8) is an albendazole prodrug, and the compound of the formula (9) is a fenbendazole prodrug.
上記の通り、一般式(I)で表される化合物及びその薬学的に許容される塩、並びに、魚介類の体内での代謝により一般式(I)で表される化合物を生成する化合物からなる群から選択された少なくとも1種は、微胞子虫防除用組成物の有効成分として使用することができる。従って、一般式(I)で表される化合物及びその薬学的に許容される塩、並びに、魚介類の体内での代謝により一般式(I)で表される化合物を生成する化合物からなる群から選択された少なくとも1種は、微胞子虫防除用組成物の製造における有効成分として使用することができる。この微胞子虫防除用組成物の製造においては、上述した薬学的に許容される任意の担体、溶媒、賦形剤、展着剤及びその他の添加剤から選択される少なくとも1種の有効成分以外の成分を配合してもよい。従って、本発明は、かかる有効成分の微胞子虫防除用組成物の製造における使用方法を含む。 The composition for controlling microspores of seafood may take any form suitable for administration to seafood, and specific examples include oral preparations, injections, and bath preparations. . These compositions may contain components other than at least one active ingredient selected from any pharmaceutically acceptable carrier, solvent, excipient, spreading agent and other additives. Known or conventionally used carriers, solvents, excipients, spreading agents and other additives can be used.
As described above, it comprises a compound represented by general formula (I) and a pharmaceutically acceptable salt thereof, and a compound that generates a compound represented by general formula (I) by metabolism in the body of fish and shellfish. At least one selected from the group can be used as an active ingredient of the composition for controlling microsporeworms. Therefore, from the group consisting of a compound represented by the general formula (I) and a pharmaceutically acceptable salt thereof, and a compound that produces a compound represented by the general formula (I) by metabolism in the body of fish and shellfish. At least one selected can be used as an active ingredient in the production of a composition for controlling microsporeworms. In the production of the composition for controlling microsporidia, at least one active ingredient selected from any of the above-mentioned pharmaceutically acceptable carriers, solvents, excipients, spreading agents and other additives. These ingredients may be blended. Therefore, this invention includes the usage method in manufacture of the composition for microspore insect control of such an active ingredient.
本発明の第2の実施の形態に係る魚介類の微胞子虫の防除方法(以下、「魚介類の微胞子虫の防除方法」又は単に「防除方法」と略称する場合がある。)は、前記一般式(I)で表され、魚介類の筋肉又は臓器への微胞子虫の感染を予防し、かつ/又は魚介類の筋肉又は臓器中での微胞子虫の増殖を抑制し、かつ/又は魚介類の体内から微胞子虫を駆除する活性を有する化合物、その薬学的に許容される塩及び魚介類の体内での代謝により前記一般式(I)で表される化合物を生成する化合物からなる群より選択される1又は複数を魚介類に投与する工程を含んでいる。なお、本発明の第1の実施の形態に係る魚介類の微胞子虫の防除用組成物の説明と重複する事項については、説明を省略する。 [Second Embodiment]
The method for controlling microspores of fish and shellfish according to the second embodiment of the present invention (hereinafter sometimes referred to as “control method of microspores of fish and shellfish” or simply “control method”). Represented by the above general formula (I), preventing the infection of seafood muscles or organs with microsporeworms and / or suppressing the growth of microspores in seafood muscles or organs, and / or Or from a compound that has the activity of controlling microsporidia from the body of fish and shellfish, a pharmaceutically acceptable salt thereof, and a compound that generates the compound represented by the general formula (I) by metabolism in the body of fish and shellfish A step of administering one or more selected from the group to seafood. In addition, about the matter which overlaps with description of the composition for controlling the microsporeworm of the seafood concerning the 1st Embodiment of this invention, description is abbreviate | omitted.
実施例1:ベコ病予防試験
1-1.フェンベンダゾールを用いたモジャコのベコ病予防試験
予防試験は、下記の手順で行った。
・試験筏 5m×5m×5m
・試験尾数 1000尾(開始体重12g)
・投与方法 経口投与(展着剤とともに給餌)
・試験期間 6週間
・使用薬剤 フェンベンダゾール(上記式(1)で表される化合物)
・投与量 20mg/kg Bw(魚体重1kgあたり20mg)
・投与間隔 6回/週 Next, examples carried out for confirming the effects of the present invention will be described.
Example 1 Bacterial Disease Prevention Test 1-1. Mojaco's Boko Disease Prevention Test Using Fenbendazole The prevention test was conducted according to the following procedure.
・ Test cage 5m × 5m × 5m
・ Number of test fish 1000 (starting weight 12g)
・ Administration method Oral administration (feeding with spreading agent)
Test period 6 weeks Drug use Fenbendazole (compound represented by the above formula (1))
・ Dose 20mg / kg Bw (20mg per kg fish weight)
・ Dose interval 6 times / week
投与開始後6週間目に、各試験区(対照区(給餌した飼料がフェンベンダゾールを含まない点を除き、上記の試験条件と同一の条件下で試験を行った。)、フェンベンダゾール区)よりモジャコ10尾ずつを取り上げ、3枚におろし、片身に微胞子虫のシスト(ベコシスト)が認められるかについて目視で検査した。ベコシストが認められた場合陽性と判定し集計した。肉眼で確認できたベコシストについて、数を確認し、1尾当たりの平均感染数を求めた。 Sampling inspection was performed according to the following procedure.
Six weeks after the start of administration, each test group (control group (test was conducted under the same conditions as described above except that the feed fed did not contain fenbendazole), fenbendazole group) ) 10 mojakos were taken out from each of them and dropped into 3 pieces, and it was visually inspected for microsporeworm cysts (becocysts) in one body. If becocyst was observed, it was determined as positive and counted. The number of becocysts confirmed with the naked eye was confirmed, and the average number of infections per fish was determined.
予防試験は、下記の手順で行った。
・試験筏 5m×5m×5m
・試験尾数 1000尾(開始体重12g)
・投与方法 経口投与(展着剤とともに給餌)
・試験期間 4週間
・使用薬剤 フルベンダゾール(上記式(6)で表される化合物)
・投与量 20mg/kg Bw(魚体重1kgあたり20mg)
・投与間隔 6回/週
・サンプリング検査手順:上記1-1.と同様 1-2. Mojaco's downy mildew prevention test using flubendazole The prevention test was conducted according to the following procedure.
・ Test cage 5m × 5m × 5m
・ Number of test fish 1000 (starting weight 12g)
・ Administration method Oral administration (feeding with spreading agent)
Test period 4 weeks Drug used Flubendazole (compound represented by the above formula (6))
・ Dose 20mg / kg Bw (20mg per kg fish weight)
・ Dose interval 6 times / week ・ Sampling test procedure: 1-1. the same as
予防試験は、下記の手順で行った。
・試験筏 5m×5m×5m
・試験尾数 1000尾(開始体重7g)
・投与方法 経口投与(展着剤とともに給餌)
・試験期間 2月間
・使用薬剤 アルベンダゾール(上記の式(3)で表される化合物)
・投与量 20mg/kg Bw(魚体重1kgあたり20mg)
・投与間隔 6回/週 1-3. Prevention test using albendazole (1)
The prevention test was conducted according to the following procedure.
・ Test cage 5m × 5m × 5m
・ Number of test fish 1000 (starting weight 7g)
・ Administration method Oral administration (feeding with spreading agent)
Test period 2 months Drug Albendazole (compound represented by the above formula (3))
・ Dose 20mg / kg Bw (20mg per kg fish weight)
・ Dose interval 6 times / week
投与開始から2週間毎に、各試験区よりモジャコを20尾(投与開始後8週目には100尾)ずつ取り上げ、3枚におろし、片身に微胞子虫のシスト(ベコシスト)が認められるかについて目視で検査する。ベコシストが認められた場合陽性と判定し集計する。肉眼で確認できたベコシストについて、数を確認し、1尾当たりの平均感染数を求める。 Sampling inspection was performed according to the following procedure.
Every 2 weeks from the start of administration, 20 mojaco (100 fish in the 8th week after the start of administration) are picked up from each test group, dropped into 3 pieces, and microsporeworm cysts (becocysts) are observed on one side Inspect visually. If becocyst is found, it is determined as positive and counted. The number of becocysts confirmed with the naked eye is confirmed, and the average number of infections per animal is determined.
アルベンダゾールの投与量を5、10mg/kg Bwに減少させた以外は、上記1-3.と同様の手順により、アルベンダゾールの投与及びサンプリング検査を行った。10mg/kg投与区では、投与開始後8週目のモジャコ100尾中、ベコシストの発生が確認された(陽性の)個体数は0であった。アルベンダゾールの投与量を5mg/kg Bwに減少させた場合、投与開始後8週目のモジャコ100尾中、3尾についてベコシストの発生が確認された。アルベンダゾールの投与量が5mg/kg Bwの場合、ベコシストの発生を完全に抑制することはできないが、対照区と比較して、ベコシストの発生は有意に抑制されている。 1-4. Prevention test using albendazole (2)
The above 1-3. Except that the dose of albendazole was reduced to 5, 10 mg / kg Bw. Albendazole administration and sampling test were performed according to the same procedure. In the 10 mg / kg administration group, the occurrence of becocysts was confirmed (positive) in 100 Mojaco fish 8 weeks after the start of administration. When the dose of albendazole was decreased to 5 mg / kg Bw, the occurrence of becocysts was confirmed in 3 out of 100 Mojaco 8 weeks after the start of administration. When the dose of albendazole is 5 mg / kg Bw, the occurrence of becocysts cannot be completely suppressed, but the occurrence of becocysts is significantly suppressed as compared with the control group.
上記1-3.と同様の手順により、16週間にわたりアルベンダゾールの投与を継続すると共に、投与開始後2週目、4週目、6週目、8週目、12週目及び16週目にサンプリング検査を行った。アルベンダゾールの投与の終了から4週間後(投与開始から20週目)にも、同様の手順によりサンプリング検査を実施した。 1-5. Prevention test using albendazole (3)
1-3. In the same manner as above, the administration of albendazole was continued for 16 weeks, and sampling tests were performed at 2 weeks, 4 weeks, 6 weeks, 8 weeks, 12 weeks and 16 weeks after the start of the administration. . Sampling test was performed by the same procedure 4 weeks after the end of the administration of albendazole (20 weeks after the start of administration).
アルベンダゾールの1回あたりの投与量及び投与間隔の異なる2通りの投与方法を用いて予防試験を行った。予防試験は、下記の手順で行った。
・試験筏 5m×5m×5m
・試験尾数 1000尾(開始体重7g)
・投与方法 経口投与(展着剤とともに給餌)
・試験期間 6月間
・使用薬剤 アルベンダゾール(上記の式(3)で表される化合物)
・投与量 試験区1:20mg/kg Bw(魚体重1kgあたり20mg)
試験区2:40mg/kg Bw(魚体重1kgあたり40mg)
・投与間隔 試験区1:6回/週(16週間にわたり投与)
試験区2:2回/2週(16週間にわたり投与) 1-6. Prevention test using albendazole (4)
A prophylaxis test was conducted using two different methods of administration of albendazole at different doses and intervals. The prevention test was conducted according to the following procedure.
・ Test cage 5m × 5m × 5m
・ Number of test fish 1000 (starting weight 7g)
・ Administration method Oral administration (feeding with spreading agent)
Test period: 6 months Drugs used Albendazole (compound represented by the above formula (3))
・ Dose Test Section 1: 20 mg / kg Bw (20 mg per kg of fish body weight)
Test plot 2: 40 mg / kg Bw (40 mg / kg fish weight)
・ Dosing interval Test group 1: 6 times / week (administration over 16 weeks)
Study group 2: Twice / 2 weeks (administration over 16 weeks)
モジャコの代わりにカンパチを用い、アルベンダゾールの投与によるベコ病の予防試験を行った。予防試験は、下記の手順で行った。
・試験筏 5m×5m×5m
・試験尾数 1000尾(開始体重50g)
・投与方法 経口投与(展着剤とともに給餌)
・試験期間 8週間
・使用薬剤 アルベンダゾール(上記の式(3)で表される化合物)
・投与量 40mg/kg Bw(魚体重1kgあたり40mg)
・投与間隔 6回/週
・サンプリング検査手順:上記1-1.と同様 1-7. Prevention test using albendazole (5)
Using amberjack instead of Mojaco, a prophylaxis test for downy mildew by administration of albendazole was conducted. The prevention test was conducted according to the following procedure.
・ Test cage 5m × 5m × 5m
・ Number of test fish 1000 (starting weight 50g)
・ Administration method Oral administration (feeding with spreading agent)
Test period 8 weeks Drug Albendazole (compound represented by the above formula (3))
・ Dose 40mg / kg Bw (40mg / kg fish weight)
・ Dose interval 6 times / week ・ Sampling test procedure: 1-1. the same as
トリクラベンダゾールを用いてカンパチのベコ病の予防試験を行った。予防試験は、下記の手順で行った。
・試験筏 5m×5m×5m
・試験尾数 1000尾(開始体重50g)
・投与方法 経口投与(展着剤とともに給餌)
・試験期間 8週間
・使用薬剤 トリクラベンダゾール(上記の式(10)で表される化合物)
・投与量 40mg/kg Bw(魚体重1kgあたり40mg)
・投与間隔 6回/週
・サンプリング検査手順:上記1-1.と同様 1-8. Prevention test using albendazole (6)
A prophylactic test for amberjack downy mildew was conducted using triclabendazole. The prevention test was conducted according to the following procedure.
・ Test cage 5m × 5m × 5m
・ Number of test animals 1000 (starting weight 50g)
・ Administration method Oral administration (feeding with spreading agent)
-Test period 8 weeks-Drugs used Triclabendazole (compound represented by the above formula (10))
・ Dose 40mg / kg Bw (40mg / kg fish weight)
・ Dose interval 6 times / week ・ Sampling test procedure: 1-1. the same as
ヒト、動物の一部の微胞子虫には、ベンズイミダゾール系の薬剤が効果を示すものがあり、これらの微胞子虫に対し、ベンズイミダゾール系の薬剤が第一選択薬として使用されている。作用機序としては、β-チューブリンのコドン198番目のグルタミン酸(E)に作用して、タンパク質生成を阻害する。ベンズイミダゾールの効果がない微胞子虫は198番目がグルタミン酸以外である。したがって、理論的には、魚介類の病原体である微胞子虫のβ-チューブリン遺伝子が、ベンズイミダゾール系の薬剤に感受性を示す微胞子虫のβ-チューブリン遺伝子と高い相同性を示すもの、さらには、コドン198番目がグルタミン酸であるものに対しては、ベンズイミダゾール系薬剤が、微胞子虫の防除用薬剤として可能性が高いと推測できる。そこで、種々の魚介類に対し感染性を示す微胞子虫からβ-チューブリン遺伝子を単離し、PCRによる増幅、シークエンシング及びアミノ酸配列の確認を行った。結果を下記の表10に示す。ヒト及びウサギ由来の微胞子虫のβ-チューブリンのアミノ酸配列は、Franzen C, Salzberger B Analysis of the beta-tubulin gene from Vittaforma corneae suggests benzimidazole resistance.Antimicrob Agents Chemother. 2008 Feb;52(2):790-3から引用した。 1-9. Prevention test using albendazole (7)
Some microsporeworms of humans and animals have an effect of benzimidazole drugs, and benzimidazole drugs are used as first-line drugs for these microsporeworms. As a mechanism of action, it acts on glutamic acid (E) at the 198th codon of β-tubulin to inhibit protein production. The 198th microsporeworm that does not have the effect of benzimidazole is other than glutamic acid. Therefore, in theory, the microsporeworm β-tubulin gene which is a pathogen of seafood shows a high homology with the microsporeworm β-tubulin gene sensitive to benzimidazole drugs, Furthermore, it can be presumed that a benzimidazole drug is highly likely to be a microsporeworm control drug for those whose codon 198 is glutamic acid. Therefore, the β-tubulin gene was isolated from microsporidia that were infectious to various fish and shellfish, amplified by PCR, sequencing and amino acid sequence confirmation. The results are shown in Table 10 below. The amino acid sequence of β-tubulin of human and rabbit microsporidia is Franzen C, Salzberger B Analysis of the beta-tubulin gene from Vittaforma corneae suggests benzimidazole resistance. Antimicrob Agents Chemother. 2008 Feb; 52 (2): 790 Quoted from -3.
2-1.アルベンダゾールを用いたベコ病感染モジャコの治療試験
治療試験は、下記の手順で行った。
・試験筏 5m×5m×5m
・試験尾数 100尾(ワクチン接種時の目視検査で明らかにベコ病に感染したことが認められた魚を選別して試験を実施)
・投与方法 経口投与(展着剤とともに給餌)
・試験期間 2月間
・使用薬剤 アルベンダゾール(上記の式(3)で表される化合物)
・投与量 50mg/kg Bw(魚体重1kgあたり50mg)
・投与間隔 6回/週 Example 2: Treatment test 2-1. Therapeutic test of downy mildew-infected mojaco using albendazole The therapeutic test was performed according to the following procedure.
・ Test cage 5m × 5m × 5m
・ Number of test fish: 100 (tests were conducted by selecting fish that were clearly infected with downy mildew by visual inspection at the time of vaccination)
・ Administration method Oral administration (feeding with spreading agent)
Test period 2 months Drug Albendazole (compound represented by the above formula (3))
・ Dose 50mg / kg Bw (50mg / kg fish weight)
・ Dose interval 6 times / week
ワクチン接種時の目視検査で、体表に凹凸が認められ、確実にベコが感染していることが認められるモジャコを選別して、無作為に対照区および試験区に分けた。投与開始後0日目、10日目、21日目に取り上げて、モジャコを3枚におろし、片身にベコシストが認められるかについて検査し、ベコ病シストが肉眼で認められた場合、陽性として集計した。 Examination method Mojaco with irregularities on the surface of the body and visual confirmation that Beko was infected by visual inspection at the time of vaccination was selected and randomly divided into a control group and a test group. Taken on the 0th, 10th, and 21st days after the start of administration, the mochaco was taken down to 3 sheets, tested for becocysts in one body, and positive if the becopathic cysts were observed with the naked eye Aggregated.
結果を表11に示す。 Treatment test results The results are shown in Table 11.
外観からベコ病シストが認められたものを選別し、投薬試験を実施した後、ベコシストが認められた陽性数の集計結果を以下に示す。投薬10日目までは、感染割合に差が認められなかったが、21日間の投薬終了後の結果では、試験区において、63尾中28尾(44.4%)が陽性であったのに対して、対照区において、82尾中54尾(65.85%)であった。この結果危険率1%未満で有意な差が認められた。 1) Percentage of infection with becosis cysts After selecting those with becosis cysts from the appearance and conducting a dosing test, the results of counting the number of positive with becocysts are shown below. There was no difference in the infection rate up to the 10th day of dosing, but the results after 21 days of dosing were positive in 28 of 63 (44.4%) in the test group. In contrast, in the control group, it was 54 out of 82 (65.85%). As a result, a significant difference was recognized at a risk rate of less than 1%.
Claims (27)
- 下記の一般式(I)で表され、魚介類の筋肉又は臓器への微胞子虫の感染を予防し、かつ/又は魚介類の筋肉又は臓器中での微胞子虫の増殖を抑制し、かつ/又は魚介類の体内から微胞子虫を駆除する活性を有する化合物、その薬学的に許容される塩及び魚介類の体内での代謝により下記一般式(I)で表される化合物を生成する化合物からなる群より選択される1又は複数を有効成分として含む魚介類の微胞子虫の防除用組成物。
R2は、アミノ基、式-NH-COOR8で表される官能基、式-N=CHR9で表される官能基、式-N=CR10(R11)で表される官能基、2-チアゾリル基、アルキルチオ基からなる群より選択される官能基であり、
R4、R6、R7は、それぞれ独立して、水素原子、ハロゲン原子、ニトロ基、スルホン酸基、カルボキシル基、シアノ基、アシル基、アルキル基、シクロアルキル基、アルコキシル基、アリール基、ヘテロアリール基、アリールオキシ基、ヘテロアリールオキシ基、置換アシル基、置換アルキル基、置換シクロアルキル基、置換アルコキシル基、置換アリール基、置換ヘテロアリール基、置換アリールオキシ基、置換ヘテロアリールオキシ基からなる群より選択される原子又は官能基であり、
R5は、水素原子、アミノ基、式-NH-COOR12で表される官能基、アルコキシル基、アルキルチオ基、アリールチオ基、アルキルスルホキシド基、アリールスルホキシド基、アシル基、置換アルコキシル基、置換アルキルチオ基、置換アルキルスルホキシド基、置換アリールスルホキシド基、置換アシル基、ハロゲン基、アリールオキシ基、置換アリールオキシ基及びR13-CO-NH-(R13はアルキル基)からなる群より選択される原子又は官能基であり、
R8、R9、R10、R11、R12は、それぞれ独立して、アルキル基、シクロアルキル基、アルコキシル基、アリール基、ヘテロアリール基、置換アシル基、置換アルキル基、置換シクロアルキル基、置換アルコキシル基、置換アリール基、置換ヘテロアリール基からなる群より選択される原子又は官能基である。 Represented by the following general formula (I), preventing the infection of the microspores in the muscles or organs of seafood and / or suppressing the growth of microspores in the muscles or organs of seafood; and Compounds having activity to control microsporidia from the body of seafood, pharmaceutically acceptable salts thereof, and compounds that produce a compound represented by the following general formula (I) by metabolism in the body of seafood A composition for controlling microsporidia of fish and shellfish containing one or more selected from the group consisting of as active ingredients.
R 2 represents an amino group, a functional group represented by the formula —NH—COOR 8 , a functional group represented by the formula —N═CHR 9 , a functional group represented by the formula —N═CR 10 (R 11 ), A functional group selected from the group consisting of a 2-thiazolyl group and an alkylthio group,
R 4 , R 6 and R 7 are each independently a hydrogen atom, halogen atom, nitro group, sulfonic acid group, carboxyl group, cyano group, acyl group, alkyl group, cycloalkyl group, alkoxyl group, aryl group, From heteroaryl group, aryloxy group, heteroaryloxy group, substituted acyl group, substituted alkyl group, substituted cycloalkyl group, substituted alkoxyl group, substituted aryl group, substituted heteroaryl group, substituted aryloxy group, substituted heteroaryloxy group An atom or functional group selected from the group consisting of
R 5 represents a hydrogen atom, an amino group, a functional group represented by the formula —NH—COOR 12 , an alkoxyl group, an alkylthio group, an arylthio group, an alkyl sulfoxide group, an aryl sulfoxide group, an acyl group, a substituted alkoxyl group, or a substituted alkylthio group. An atom selected from the group consisting of a substituted alkyl sulfoxide group, a substituted aryl sulfoxide group, a substituted acyl group, a halogen group, an aryloxy group, a substituted aryloxy group and R 13 —CO—NH— (wherein R 13 is an alkyl group), Functional group,
R 8 , R 9 , R 10 , R 11 , R 12 are each independently an alkyl group, cycloalkyl group, alkoxyl group, aryl group, heteroaryl group, substituted acyl group, substituted alkyl group, substituted cycloalkyl group , A substituted alkoxyl group, a substituted aryl group, or a substituted heteroaryl group. - 前記一般式(I)で表される化合物が、下記の式(1)から(7)及び(10)で表される化合物のいずれかであり、前記一般式(I)で表される化合物を生成する化合物が下記の式(8)及び(9)で表される化合物のいずれかである請求項1記載の魚介類の微胞子虫の防除用組成物。
- 前記魚介類が、スズキ目(Perciformes)又はカレイ目(Pleuronectiformes)に属する魚類である請求項1又は2記載の魚介類の微胞子虫の防除用組成物。 3. The composition for controlling microspores of fish and shellfish according to claim 1 or 2, wherein the fish and shellfish are fish belonging to the order of Perciformes or Pleuronectiformes.
- 前記魚介類が、スズキ目サバ科(Scombridae)マグロ属(Thunnus)、スズキ目アジ科(Carangidae)ブリ属(Seriola)、スズキ目タイ科(Sparidae)マダイ属(Chrysophrys)、カレイ目ヒラメ科(Paralichthyidae)ヒラメ属(Paralichthys)又はカレイ目カレイ科(Pleuronectidae)マツカワ属(Verasper)に属する魚類である請求項3記載の魚介類の微胞子虫の防除用組成物。 The seafood includes Persian Scombridae (Thunnus), Persian Carridae (Seriola), Persian (Sparidae), Chrysophrys, Paralichthyidae (Paralichthyidae) 4. The composition for controlling microspores of fish and shellfish according to claim 3, which is a fish belonging to the genus Paralichthys or the genus Pleuronectidae or Verasper.
- 前記微胞子虫が、Microsporidium属に属する微胞子虫である請求項1から4のいずれか1項記載の魚介類の微胞子虫の防除用組成物。 The composition for controlling microspores of seafood according to any one of claims 1 to 4, wherein the microspores are microsporidia belonging to the genus Microsporidium.
- 前記微胞子虫が、Microsporidium seriolaeである請求項5記載の魚介類の微胞子虫の防除用組成物。 6. The composition for controlling microspores of seafood according to claim 5, wherein the microsporeworm is Microsporidium seriolae.
- 経口投与剤である請求項1から6のいずれか1項に記載の魚介類の微胞子虫の防除用組成物。 The composition for controlling microspores of fish and shellfish according to any one of claims 1 to 6, which is an oral administration agent.
- 養魚用飼料である請求項1から6のいずれか1項に記載の魚介類の微胞子虫の防除用組成物。 The composition for controlling seafood microsporeworms according to any one of claims 1 to 6, which is a feed for fish farming.
- 注射剤である請求項1から6のいずれか1項に記載の魚介類の微胞子虫の防除用組成物。 The composition for controlling microspores of seafood according to any one of claims 1 to 6, which is an injection.
- 薬浴剤である請求項1から6のいずれか1項に記載の魚介類の微胞子虫の防除用組成物。 The composition for controlling microspores of fish and shellfish according to any one of claims 1 to 6, which is a bath salt.
- 下記の一般式(I)で表され、魚介類の筋肉又は臓器への微胞子虫の感染を予防し、かつ/又は魚介類の筋肉又は臓器中での微胞子虫の増殖を抑制し、かつ/又は魚介類の体内から微胞子虫を駆除する活性を有する化合物、その薬学的に許容される塩及び魚介類の体内での代謝により前記一般式(I)で表される化合物を生成する化合物からなる群より選択される1又は複数を有効成分として含む組成物を魚介類に投与する工程を含む魚介類の微胞子虫の防除方法。
R2は、アミノ基、式-NH-COOR8で表される官能基、式-N=CHR9で表される官能基、式-N=CR10(R11)で表される官能基、2-チアゾリル基、アルキルチオ基からなる群より選択される官能基であり、
R4、R6、R7は、それぞれ独立して、水素原子、ハロゲン原子、ニトロ基、スルホン酸基、カルボキシル基、シアノ基、アシル基、アルキル基、シクロアルキル基、アルコキシル基、アリール基、ヘテロアリール基、アリールオキシ基、ヘテロアリールオキシ基、置換アシル基、置換アルキル基、置換シクロアルキル基、置換アルコキシル基、置換アリール基、置換ヘテロアリール基、置換アリールオキシ基、置換ヘテロアリールオキシ基からなる群より選択される原子又は官能基であり、
R5は、水素原子、アミノ基、式-NH-COOR12で表される官能基、アルコキシル基、アルキルチオ基、アリールチオ基、アルキルスルホキシド基、アリールスルホキシド基、アシル基、置換アルコキシル基、置換アルキルチオ基、置換アルキルスルホキシド基、置換アリールスルホキシド基、置換アシル基、ハロゲン基、アリールオキシ基、置換アリールオキシ基及びR13-CO-NH-(R13はアルキル基)からなる群より選択される原子又は官能基であり、
R8、R9、R10、R11、R12は、それぞれ独立して、アルキル基、シクロアルキル基、アルコキシル基、アリール基、ヘテロアリール基、置換アシル基、置換アルキル基、置換シクロアルキル基、置換アルコキシル基、置換アリール基、置換ヘテロアリール基からなる群より選択される原子又は官能基である。 Represented by the following general formula (I), preventing the infection of the microspores in the muscles or organs of seafood and / or suppressing the growth of microspores in the muscles or organs of seafood; and / Or a compound having an activity to control microsporidia from the body of fish and shellfish, a pharmaceutically acceptable salt thereof, and a compound that generates the compound represented by the general formula (I) by metabolism in the body of fish and shellfish A method for controlling microsporeworms of fish and shellfish, comprising a step of administering to the fish and shellfish a composition comprising one or more selected from the group consisting of as active ingredients.
R 2 represents an amino group, a functional group represented by the formula —NH—COOR 8 , a functional group represented by the formula —N═CHR 9 , a functional group represented by the formula —N═CR 10 (R 11 ), A functional group selected from the group consisting of a 2-thiazolyl group and an alkylthio group,
R 4 , R 6 and R 7 are each independently a hydrogen atom, halogen atom, nitro group, sulfonic acid group, carboxyl group, cyano group, acyl group, alkyl group, cycloalkyl group, alkoxyl group, aryl group, From heteroaryl group, aryloxy group, heteroaryloxy group, substituted acyl group, substituted alkyl group, substituted cycloalkyl group, substituted alkoxyl group, substituted aryl group, substituted heteroaryl group, substituted aryloxy group, substituted heteroaryloxy group An atom or functional group selected from the group consisting of
R 5 represents a hydrogen atom, an amino group, a functional group represented by the formula —NH—COOR 12 , an alkoxyl group, an alkylthio group, an arylthio group, an alkyl sulfoxide group, an aryl sulfoxide group, an acyl group, a substituted alkoxyl group, or a substituted alkylthio group. An atom selected from the group consisting of a substituted alkyl sulfoxide group, a substituted aryl sulfoxide group, a substituted acyl group, a halogen group, an aryloxy group, a substituted aryloxy group and R 13 —CO—NH— (wherein R 13 is an alkyl group), Functional group,
R 8 , R 9 , R 10 , R 11 , R 12 are each independently an alkyl group, cycloalkyl group, alkoxyl group, aryl group, heteroaryl group, substituted acyl group, substituted alkyl group, substituted cycloalkyl group , A substituted alkoxyl group, a substituted aryl group, or a substituted heteroaryl group. - 前記一般式(I)で表される化合物が、下記の式(1)から(7)及び(10)で表される化合物のいずれかであり、前記一般式(I)で表される化合物を生成する化合物が下記の式(8)及び(9)で表される化合物のいずれかである請求項11記載の魚介類の微胞子虫の防除方法。
- 前記魚介類が、スズキ目(Perciformes)又はカレイ目(Pleuronectiformes)に属する魚類である請求項11又は12記載の魚介類の微胞子虫の防除方法。 13. The method for controlling microspores of seafood according to claim 11 or 12, wherein the seafood is a fish belonging to the order Perciformes or Pleuronectiformes.
- 前記魚介類が、スズキ目サバ科(Scombridae)マグロ属(Thunnus)、スズキ目アジ科(Carangidae)ブリ属(Seriola)、スズキ目タイ科(Sparidae)マダイ属(Chrysophrys)、カレイ目ヒラメ科(Paralichthyidae)ヒラメ属(Paralichthys)又はカレイ目カレイ科(Pleuronectidae)マツカワ属(Verasper)に属する魚類である請求項13記載の魚介類の微胞子虫の防除方法。 The seafood includes Persian Scombridae (Thunnus), Persian Carridae (Seriola), Persian (Sparidae), Chrysophrys, Paralichthyidae (Paralichthyidae) 14. The method for controlling microspores of fish and shellfish according to claim 13, which is a fish belonging to the genus Paralichthys or the genus Pleuronectidae or Verasper.
- 前記微胞子虫が、Microsporidium属に属する微胞子虫である請求項11から14のいずれか1項記載の魚介類の微胞子虫の防除方法。 The method for controlling microspores of fish and shellfish according to any one of claims 11 to 14, wherein the microspores are microspores belonging to the genus Microsporidium.
- 前記微胞子虫が、Microsporidium seriolaeである請求項15記載の魚介類の微胞子虫の防除方法。 The method of controlling a microspore of a seafood according to claim 15, wherein the microsporidia is Microsporidium seriolae.
- 前記魚介類への投与が経口投与である請求項11から16のいずれか1項記載の魚介類の微胞子虫の防除方法。 The method for controlling microsporeworms of seafood according to any one of claims 11 to 16, wherein the administration to the seafood is oral administration.
- 請求項7又は8記載の魚介類の微胞子虫の防除用組成物を、その有効成分の用量が0.1mg/kg以上100mg/kg以下となるよう、単回或いは1日以上180日以下の間隔で複数回経口投与することにより魚介類の微胞子虫感染を予防する請求項17記載の魚介類の微胞子虫の防除方法。 The composition for controlling microspores of fish and shellfish according to claim 7 or 8, wherein the dose of the active ingredient is 0.1 mg / kg or more and 100 mg / kg or less at a single time or 1 day or more and 180 days or less. The method for controlling microsporeworms of seafood according to claim 17, wherein the microsporeworm infection of seafood is prevented by oral administration multiple times at intervals.
- 請求項7又は8記載の魚介類の微胞子虫の防除用組成物を、その有効成分の用量が20mg/kg以上400mg/kg以下となるよう、単回或いは6時間以上180日以下の間隔で複数回経口投与することにより魚介類の微胞子虫を駆除する請求項17記載の魚介類の微胞子虫の防除方法。 9. The composition for controlling microspores of seafood according to claim 7 or 8, wherein the dose of the active ingredient is 20 mg / kg or more and 400 mg / kg or less at a single time or at intervals of 6 hours or more and 180 days or less. 18. The method for controlling seafood microsporeworms according to claim 17, wherein the microsporeworms of seafood are controlled by oral administration multiple times.
- 請求項7又は8記載の魚介類の微胞子虫の防除用組成物を、その有効成分の用量が20mg/kg以上400mg/kg以下となるよう、3日以上180日以下の間隔で複数回経口投与することにより魚介類の微胞子虫の駆除及び再感染の予防を行う請求項17記載の魚介類の微胞子虫の防除方法。 9. The composition for controlling microspores of seafood according to claim 7 or 8, wherein the active ingredient dose is 20 mg / kg or more and 400 mg / kg or less at an interval of 3 days or more and 180 days or less. The method for controlling microspores of fish and shellfish according to claim 17, wherein the microsporeworms of fish and shellfish are controlled and reinfection is prevented by administration.
- 前記魚介類の微胞子虫の防除用組成物を、5日以上21日以下の間隔で経口投与することを特徴とする請求項20記載の魚介類の微胞子虫の防除方法。 The method for controlling microspores of fish and shellfish according to claim 20, wherein the composition for controlling microspores of fish and shellfish is orally administered at intervals of 5 days or more and 21 days or less.
- 前記複数回の経口投与を1サイクルとし、前記サイクルを、3日以上180日以下の間隔で反復することを特徴とする請求項20又は21記載の魚介類の微胞子虫の防除方法。 The method for controlling microspores of fish and shellfish according to claim 20 or 21, wherein the plurality of oral administrations are defined as one cycle, and the cycle is repeated at intervals of 3 days or more and 180 days or less.
- 前記魚介類への投与が筋肉注射又は腹腔内注射である請求項11から16のいずれか1項記載の魚介類の微胞子虫の防除方法。 The method for controlling microsporeworms of seafood according to any one of claims 11 to 16, wherein the administration to the seafood is intramuscular injection or intraperitoneal injection.
- 前記魚介類への投与が薬浴中での浸漬投与である請求項11から16のいずれか1項記載の魚介類の微胞子虫の防除方法。 The method for controlling microsporeworms of fish and shellfish according to any one of claims 11 to 16, wherein the fish and shellfish are administered by immersion in a medicine bath.
- 請求項10記載の魚介類の微胞子虫の防除用組成物を、その有効成分の濃度が1から1000ppmとなる量だけ含有している薬浴液中で、魚介類への浸漬投与を行う請求項24記載の魚介類の微胞子虫の防除方法。 Claims for immersing administration to seafood in a medicinal bath solution containing the composition for controlling microspores of seafood according to claim 10 in an amount such that the concentration of the active ingredient is 1 to 1000 ppm. Item 25. A method for controlling microspores of seafood according to Item 24.
- 下記の一般式(I)で表される化合物及びその薬学的に許容される塩、並びに魚介類の体内での代謝により下記一般式(I)で表される化合物を生成する化合物からなる群より選択される1又は複数の、魚介類の筋肉又は臓器への微胞子虫の感染を予防し、かつ/又は魚介類の筋肉又は臓器中での微胞子虫の増殖を抑制し、かつ/又は魚介類の体内から微胞子虫を駆除するための使用。
R2は、アミノ基、式-NH-COOR8で表される官能基、式-N=CHR9で表される官能基、式-N=CR10(R11)で表される官能基、2-チアゾリル基、アルキルチオ基からなる群より選択される官能基であり、
R4、R6、R7は、それぞれ独立して、水素原子、ハロゲン原子、ニトロ基、スルホン酸基、カルボキシル基、シアノ基、アシル基、アルキル基、シクロアルキル基、アルコキシル基、アリール基、ヘテロアリール基、アリールオキシ基、ヘテロアリールオキシ基、置換アシル基、置換アルキル基、置換シクロアルキル基、置換アルコキシル基、置換アリール基、置換ヘテロアリール基、置換アリールオキシ基、置換ヘテロアリールオキシ基からなる群より選択される原子又は官能基であり、
R5は、水素原子、アミノ基、式-NH-COOR12で表される官能基、アルコキシル基、アルキルチオ基、アリールチオ基、アルキルスルホキシド基、アリールスルホキシド基、アシル基、置換アルコキシル基、置換アルキルチオ基、置換アルキルスルホキシド基、置換アリールスルホキシド基、置換アシル基、ハロゲン基、アリールオキシ基、置換アリールオキシ基及びR13-CO-NH-(R13はアルキル基)からなる群より選択される原子又は官能基であり、
R8、R9、R10、R11、R12は、それぞれ独立して、アルキル基、シクロアルキル基、アルコキシル基、アリール基、ヘテロアリール基、置換アシル基、置換アルキル基、置換シクロアルキル基、置換アルコキシル基、置換アリール基、置換ヘテロアリール基からなる群より選択される原子又は官能基である。 From the group consisting of a compound represented by the following general formula (I) and a pharmaceutically acceptable salt thereof, and a compound that produces a compound represented by the following general formula (I) by metabolism in the body of fish and shellfish Prevention of infection of microsporeworms in one or more selected muscles or organs of seafood and / or suppression of microsporeworm growth in muscles or organs of seafood and / or seafood Use to control microsporidia from the body of moss.
R 2 represents an amino group, a functional group represented by the formula —NH—COOR 8 , a functional group represented by the formula —N═CHR 9 , a functional group represented by the formula —N═CR 10 (R 11 ), A functional group selected from the group consisting of a 2-thiazolyl group and an alkylthio group,
R 4 , R 6 and R 7 are each independently a hydrogen atom, halogen atom, nitro group, sulfonic acid group, carboxyl group, cyano group, acyl group, alkyl group, cycloalkyl group, alkoxyl group, aryl group, From heteroaryl group, aryloxy group, heteroaryloxy group, substituted acyl group, substituted alkyl group, substituted cycloalkyl group, substituted alkoxyl group, substituted aryl group, substituted heteroaryl group, substituted aryloxy group, substituted heteroaryloxy group An atom or functional group selected from the group consisting of
R 5 represents a hydrogen atom, an amino group, a functional group represented by the formula —NH—COOR 12 , an alkoxyl group, an alkylthio group, an arylthio group, an alkyl sulfoxide group, an aryl sulfoxide group, an acyl group, a substituted alkoxyl group, or a substituted alkylthio group. An atom selected from the group consisting of a substituted alkyl sulfoxide group, a substituted aryl sulfoxide group, a substituted acyl group, a halogen group, an aryloxy group, a substituted aryloxy group and R 13 —CO—NH— (wherein R 13 is an alkyl group), Functional group,
R 8, R 9, R 10 , R 11, R 12 are each independently an alkyl group, a cycloalkyl group, an alkoxyl group, an aryl group, a heteroaryl group, a substituted acyl group, a substituted alkyl group, a substituted cycloalkyl group , A substituted alkoxyl group, a substituted aryl group, or a substituted heteroaryl group. - 下記の一般式(I)で表される化合物及びその薬学的に許容される塩、並びに魚介類の体内での代謝により下記一般式(I)で表される化合物を生成する化合物からなる群より選択される1又は複数の、魚介類の筋肉又は臓器への微胞子虫の感染を予防し、かつ/又は魚介類の筋肉又は臓器中での微胞子虫の増殖を抑制し、かつ/又は魚介類の体内から微胞子虫を駆除するための防除用組成物の製造における有効成分としての使用。
R2は、アミノ基、式-NH-COOR8で表される官能基、式-N=CHR9で表される官能基、式-N=CR10(R11)で表される官能基、2-チアゾリル基、アルキルチオ基からなる群より選択される官能基であり、
R4、R6、R7は、それぞれ独立して、水素原子、ハロゲン原子、ニトロ基、スルホン酸基、カルボキシル基、シアノ基、アシル基、アルキル基、シクロアルキル基、アルコキシル基、アリール基、ヘテロアリール基、アリールオキシ基、ヘテロアリールオキシ基、置換アシル基、置換アルキル基、置換シクロアルキル基、置換アルコキシル基、置換アリール基、置換ヘテロアリール基、置換アリールオキシ基、置換ヘテロアリールオキシ基からなる群より選択される原子又は官能基であり、
R5は、水素原子、アミノ基、式-NH-COOR12で表される官能基、アルコキシル基、アルキルチオ基、アリールチオ基、アルキルスルホキシド基、アリールスルホキシド基、アシル基、置換アルコキシル基、置換アルキルチオ基、置換アルキルスルホキシド基、置換アリールスルホキシド基、置換アシル基、ハロゲン基、アリールオキシ基、置換アリールオキシ基及びR13-CO-NH-(R13はアルキル基)からなる群より選択される原子又は官能基であり、
R8、R9、R10、R11、R12は、それぞれ独立して、アルキル基、シクロアルキル基、アルコキシル基、アリール基、ヘテロアリール基、置換アシル基、置換アルキル基、置換シクロアルキル基、置換アルコキシル基、置換アリール基、置換ヘテロアリール基からなる群より選択される原子又は官能基である。
From the group consisting of a compound represented by the following general formula (I) and a pharmaceutically acceptable salt thereof, and a compound that produces a compound represented by the following general formula (I) by metabolism in the body of fish and shellfish Prevention of infection of microsporeworms in one or more selected muscles or organs of seafood and / or suppression of microsporeworm growth in muscles or organs of seafood and / or seafood Use as an active ingredient in the manufacture of a control composition for controlling microsporidia from the body of mosses.
R 2 represents an amino group, a functional group represented by the formula —NH—COOR 8 , a functional group represented by the formula —N═CHR 9 , a functional group represented by the formula —N═CR 10 (R 11 ), A functional group selected from the group consisting of a 2-thiazolyl group and an alkylthio group,
R 4 , R 6 and R 7 are each independently a hydrogen atom, halogen atom, nitro group, sulfonic acid group, carboxyl group, cyano group, acyl group, alkyl group, cycloalkyl group, alkoxyl group, aryl group, From heteroaryl group, aryloxy group, heteroaryloxy group, substituted acyl group, substituted alkyl group, substituted cycloalkyl group, substituted alkoxyl group, substituted aryl group, substituted heteroaryl group, substituted aryloxy group, substituted heteroaryloxy group An atom or functional group selected from the group consisting of
R 5 represents a hydrogen atom, an amino group, a functional group represented by the formula —NH—COOR 12 , an alkoxyl group, an alkylthio group, an arylthio group, an alkyl sulfoxide group, an aryl sulfoxide group, an acyl group, a substituted alkoxyl group, or a substituted alkylthio group. An atom selected from the group consisting of a substituted alkyl sulfoxide group, a substituted aryl sulfoxide group, a substituted acyl group, a halogen group, an aryloxy group, a substituted aryloxy group and R 13 —CO—NH— (wherein R 13 is an alkyl group), Functional group,
R 8 , R 9 , R 10 , R 11 , R 12 are each independently an alkyl group, cycloalkyl group, alkoxyl group, aryl group, heteroaryl group, substituted acyl group, substituted alkyl group, substituted cycloalkyl group , A substituted alkoxyl group, a substituted aryl group, or a substituted heteroaryl group.
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2017239880A AU2017239880B2 (en) | 2016-03-31 | 2017-03-30 | Composition for controlling microsporidia in fishes and method for controlling microsporidia in fishes using same |
US16/089,226 US10813914B2 (en) | 2016-03-31 | 2017-03-30 | Composition for controlling microsporidia in fishes and method for controlling microsporidia in fishes using same |
KR1020187030805A KR20180125565A (en) | 2016-03-31 | 2017-03-30 | A composition for controlling microorganisms and a method for controlling microorganisms |
EP17775503.0A EP3437642A4 (en) | 2016-03-31 | 2017-03-30 | Composition for controlling microsporidia in fishes and method for controlling microsporidia in fishes using same |
MX2018011974A MX2018011974A (en) | 2016-03-31 | 2017-03-30 | Composition for controlling microsporidia in fishes and method for controlling microsporidia in fishes using same. |
CN201780021272.1A CN108883095B (en) | 2016-03-31 | 2017-03-30 | Composition for controlling scale-like microsporidian, and method for controlling scale-like microsporidian using same |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016-070840 | 2016-03-31 | ||
JP2016070840 | 2016-03-31 | ||
JP2017-047531 | 2017-03-13 | ||
JP2017047531A JP6343796B2 (en) | 2016-03-31 | 2017-03-13 | Composition for controlling microspores of seafood and method for controlling microspores of seafood using the same |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2017170970A1 true WO2017170970A1 (en) | 2017-10-05 |
Family
ID=59965949
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2017/013489 WO2017170970A1 (en) | 2016-03-31 | 2017-03-30 | Composition for controlling microsporidia in fishes and method for controlling microsporidia in fishes using same |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2017170970A1 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS57106621A (en) * | 1980-12-24 | 1982-07-02 | Takeda Chem Ind Ltd | Preventing agent and remedy for fish disease |
JP2002220309A (en) * | 2001-01-29 | 2002-08-09 | Kyowa Hakko Kogyo Co Ltd | Exterminator and exterminating method of benedenia |
JP2004511471A (en) * | 2000-10-06 | 2004-04-15 | バイエル アクチェンゲゼルシャフト | N-alkoxyalkyl-substituted benzimidazoles and their use as drugs against parasitic protozoa |
-
2017
- 2017-03-30 WO PCT/JP2017/013489 patent/WO2017170970A1/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS57106621A (en) * | 1980-12-24 | 1982-07-02 | Takeda Chem Ind Ltd | Preventing agent and remedy for fish disease |
JP2004511471A (en) * | 2000-10-06 | 2004-04-15 | バイエル アクチェンゲゼルシャフト | N-alkoxyalkyl-substituted benzimidazoles and their use as drugs against parasitic protozoa |
JP2002220309A (en) * | 2001-01-29 | 2002-08-09 | Kyowa Hakko Kogyo Co Ltd | Exterminator and exterminating method of benedenia |
Non-Patent Citations (2)
Title |
---|
SCHMAHL G. ET AL.: "Treatment of fish parasites. 11. Effects of different benzimidazole derivatives (albendazole, mebendazole, fenbendazole) on Glugea anomala, Moniez, 1887 (Microsporidia): Ultrastructural aspects and efficacy studies", PARASITOLOGY RESEARCH, vol. 84, no. 1, 1 February 1998 (1998-02-01), pages 41 - 49, XP055578950 * |
See also references of EP3437642A4 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6565075B2 (en) | Therapeutic composition for oral administration of fish and shellfish beko disease and method for treating fish and shellfish beko disease using the same | |
TWI488625B (en) | Use of fungicides for the treatment of fish mycoses | |
JP6784866B1 (en) | A therapeutic agent for diseases caused by microsporidia and myxosporea parasitizing marine fish | |
KR101317083B1 (en) | Parasite control agent for fish, and parasite control method for fish | |
JP5771203B2 (en) | Fish parasite control agent and control method | |
US9265777B2 (en) | Antiparasitic agent for fish and method of controlling proliferation of fish parasites | |
US20150272931A1 (en) | New Treatment | |
JPS6339569B2 (en) | ||
WO2017170970A1 (en) | Composition for controlling microsporidia in fishes and method for controlling microsporidia in fishes using same | |
JPH07188009A (en) | Anti-coccidium composition | |
JP7424983B2 (en) | How to prevent muscle melting in salmonids | |
JP4695766B2 (en) | Fish parasite control agent and control method | |
JPH07103036B2 (en) | Method for preventing and treating nodular disease of fish | |
JPS6160041B2 (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: MX/A/2018/011974 Country of ref document: MX |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 20187030805 Country of ref document: KR Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2017239880 Country of ref document: AU Date of ref document: 20170330 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2017775503 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2017775503 Country of ref document: EP Effective date: 20181031 |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 17775503 Country of ref document: EP Kind code of ref document: A1 |